drugset / Trial / NCT00128882

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

NCT00128882 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to describe the effect of anti-D on symptoms and platelet count in children suffering from unexplainable low platelet counts, when anti-D is administered as an injection under the skin. The hypothesis is that the injection with anti-D under the skin is as effective as anti-D given in a vein.

Timeline

Start
2004-11
Primary completion
2008-01
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Anti-D Unknown — Subcutaneous